|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Lanthanum citrate>> Market Analysis Reports |
Market Analysis Reports of Lanthanum citrate |
|
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028 ... cation, such as carbonate, acetate, oxyhydroxide, or citrate, to form a compound that is nonabsorbable ... Iron Based Phosphate Binders Lanthanum Carbonate Others The report ... binders, iron based phosphate binders, lanthanum carbonate, and others. According to ... Hyperphosphatemia Drugs Market Report by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033 ... cation, such as carbonate, acetate, oxyhydroxide, or citrate, to form a compound that is nonabsorbable ... Iron Based Phosphate Binders Lanthanum Carbonate Others The report ... binders, iron based phosphate binders, lanthanum carbonate, and others. According to ... Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In ... Hyperphosphatemia - Pipeline Insight, 2021 ... . Hyperphosphatemia Emerging Drugs FC818 (ferric citrate): PUMC Pharmaceutical FC818 is a novel non ... (ferric citrate) VS 505 Tenapanor PT20 EOS789 DS-2330b JPH 101 Fermagate Lanthanum dioxycarbonate Lanthanum ... Hyperphosphatemia - Pipeline Review, H1 2020 Hyperphosphatemia - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia - Pipeline Review, H1 2020, provides an overview of the Hyperphosphatemia (Nutritional Disorders) ... |